Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors

HH Lee, P Swanson, JD Rosenblatt, ISY Chen… - The Lancet, 1991 - Elsevier
The clinical significance of human T-cell lymphotropic virus type II (HTLV-II) infection, unlike
that of HTLV-I, is unknown, and the major known association of HTLV-II seropositivity is with …

HTLV-III in symptom-free seronegative persons

SZ Salahuddin, PD Markham, RR Redfield, M Essex… - The Lancet, 1984 - Elsevier
Of 96 patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex
and healthy individuals at risk for AIDS, 4 had no detectable antibodies to viral proteins …

Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain

RC Cheingsong-Popov, RA Weiss, A Dalgleish… - The Lancet, 1984 - Elsevier
Abstract 2000 persons in the UK were examined serologically for antibodies to human T-
lymphotropic virus type III (HTLV-III). Sera reacting in a membrane immunofluorescence …

Diversity of clinical spectrum of HTLV-III infection

SL Valle, A Ranki, J Suni, C Saxinger, J Antonen… - The Lancet, 1985 - Elsevier
In a prospective follow-up volunteer study lasting 4 to 16 months, 17 of 200 homosexual
men living in Finland had antibodies to human T-lymphotrophic virus type III (HTLV-III). 1 …

Seroprevalence and epidemiological correlates of HTLV-I infection in US blood donors

AE Williams, CT Fang, DJ Slamon, BJ Poiesz… - Science, 1988 - science.org
Screening for human T-lymphotropic virus type I (HTLV-I) antibodies was performed on sera
from 39,898 blood donors at eight blood centers in geographically distinct areas of the …

Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome

B Safai, JE Groopman, M Popovic, J Schüpbach… - The Lancet, 1984 - Elsevier
In a double-blind study, sera of 34 patients with acquired immunodeficiency syndrome
(AIDS), 19 patients with lymphadenopathy syndrome, and 14 homosexual men with an …

HTLV-I-specific antibody in AIDS patients and others at risk

M Robert-Guroff, B Safai, EP Gelmann, PWA Mansell… - The Lancet, 1984 - Elsevier
Serum samples from 440 acquired immunodeficiency syndrome (AIDS) patients or
individuals at risk for AIDS were examined by the enzyme-linked immunosorbent assay …

Prevalence of antibodies to HTLV-I,-II, and-III in intravenous drug abusers from an AIDS endemic region

M Robert-Guroff, SH Weiss, JA Giron, AM Jennings… - Jama, 1986 - jamanetwork.com
Antibody prevalences for human T-cell lymphotropic virus (HTLV) types I, II, and III were
determined for 56 intravenous drug abusers from Queens, NY. While control serum samples …

[PDF][PDF] Possible risk to recipients of blood from donors carrying serum markers of human T-cell leukaemia virus

WC Saxinger, RC Gallo - The Lancet, 1982 - academia.edu
unpublished), supporting the infectious nature of HTLV. Nevertheless, the mechanism of
transmission of HTLV remains unproven. Since the incidence of HTLV seropositive T-cell …

Epidemiologic features of HTLV-II: serologic and molecular evidence

GW Lowis, WA Sheremata, A Minagar - Annals of epidemiology, 2002 - Elsevier
PURPOSE: A literature review was performed of the three principal subpopulations most
commonly associated with human T-cell lymphotropic virus type II (HTLV-II) with the view of …